France backs COVID-19 vaccine IP waiver
14-06-2021
AIPPI weighs in on COVID waiver
17-05-2021
siam.pukkato / Shutterstock.com
Talks over a COVID-19 vaccine waiver ended this week at the World Trade Organization (WTO) in Geneva, with an agreement to work towards a text-based response to the plan.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
COVID-19, patents, compulsory licensing, vaccines, Pfizer, Moderna, Astrazeneca
